Five Prime Therapeutics, Inc.

Report date
3/31/2021
Quarter
2021 Q1
Filed
4/26/2021
Shares
341,463
Value ($000)
12,863
Weight
0.1%
2019 Q4 - 2021 Q1 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).